- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
South Korean Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
4
1 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
4 companies
Dong-A Socio Holdings
Market Cap: ₩740.1b
Engages in the pharmaceutical business in South Korea.
A000640
₩113,800.00
7D
2.6%
1Y
15.4%
JW Pharmaceutical
Market Cap: ₩533.5b
Manufactures and sells medicines and medical supplies in Japan and internationally.
New
A001060
₩23,000.00
7D
0.9%
1Y
-22.3%
Sinsin Pharmaceutical
Market Cap: ₩93.8b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩6,090.00
7D
-0.2%
1Y
14.7%
P&K Skin Research Center
Market Cap: ₩84.2b
Engages in the evaluation and research of dermatological products in South Korea.
A347740
₩2,900.00
7D
0.7%
1Y
-0.7%